AATec Medical
Product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases.
1
Funding Rounds
$2.7m
Money raised
Overview
Product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases.
- Website:
- Business model: B2C
- Headquarters: Munich
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company AATec Medical has raised a total of $2.7m in funding over 1 rounds.
Key Insights:
- AATec Medical July 2023 Seed Funding Round: $2.7m
AATec Medical July 2023 Seed Funding Round
$2.7m